IRIS - Res&Arch Institutional Research Information System - Research & Archive

ROSATI, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.210
EU - Europa 3.363
AS - Asia 2.905
SA - Sud America 522
Continente sconosciuto - Info sul continente non disponibili 274
AF - Africa 88
OC - Oceania 1
Totale 11.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.097
SG - Singapore 1.306
IT - Italia 606
IE - Irlanda 521
SE - Svezia 501
BR - Brasile 417
UA - Ucraina 414
CN - Cina 395
HK - Hong Kong 382
RU - Federazione Russa 366
VN - Vietnam 357
DE - Germania 243
FI - Finlandia 190
FR - Francia 161
GB - Regno Unito 120
KR - Corea 100
IN - India 73
BD - Bangladesh 61
CA - Canada 48
TR - Turchia 47
RO - Romania 41
AR - Argentina 39
PL - Polonia 39
MX - Messico 37
BE - Belgio 29
NL - Olanda 29
UZ - Uzbekistan 28
AT - Austria 25
IQ - Iraq 23
PK - Pakistan 23
ZA - Sudafrica 23
JP - Giappone 22
ES - Italia 20
EC - Ecuador 19
MA - Marocco 16
CZ - Repubblica Ceca 14
ID - Indonesia 13
VE - Venezuela 13
CH - Svizzera 11
CO - Colombia 11
LT - Lituania 11
GR - Grecia 10
JM - Giamaica 10
CL - Cile 8
CI - Costa d'Avorio 7
DZ - Algeria 7
JO - Giordania 7
LB - Libano 7
PH - Filippine 7
SA - Arabia Saudita 7
EG - Egitto 6
EU - Europa 6
KE - Kenya 6
KZ - Kazakistan 6
MY - Malesia 6
PE - Perù 6
PY - Paraguay 6
TN - Tunisia 6
ET - Etiopia 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AZ - Azerbaigian 4
CR - Costa Rica 4
DO - Repubblica Dominicana 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
AM - Armenia 2
AO - Angola 2
GT - Guatemala 2
KH - Cambogia 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
ZW - Zimbabwe 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
DJ - Gibuti 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HT - Haiti 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
Totale 11.087
Salva come PNG Salva come JPEG
Città #
Singapore 958
Chandler 564
Dublin 520
Hong Kong 381
San Jose 358
San Mateo 333
Ashburn 294
Perugia 226
Dong Ket 175
Santa Clara 166
Boardman 159
Jacksonville 155
Ann Arbor 143
Moscow 116
Medford 105
Princeton 104
Lauterbourg 101
Seoul 100
Beijing 96
Munich 88
Wilmington 79
Los Angeles 76
Altamura 67
Andover 66
Ho Chi Minh City 61
New York 55
Des Moines 51
Helsinki 50
Lawrence 47
The Dalles 46
São Paulo 45
Piscataway 42
Turku 41
Saint Petersburg 39
Woodbridge 36
Bucharest 33
Dallas 32
Hanoi 32
Brussels 29
Warsaw 25
Phoenix 23
Houston 22
Tokyo 22
Norwalk 21
Frankfurt am Main 20
Council Bluffs 19
Chennai 18
Izmir 17
Rome 17
Brooklyn 15
Dearborn 15
Milan 15
Orem 15
Shanghai 15
Tashkent 15
Foligno 14
Rio de Janeiro 14
Toronto 14
Amsterdam 13
Belo Horizonte 13
Montreal 13
Vienna 13
Curitiba 12
London 12
Mexico City 12
Atlanta 11
Johannesburg 11
Boston 10
Buffalo 10
Falls Church 10
Guangzhou 10
Hefei 10
San Francisco 10
Stockholm 10
Ankara 9
Assisi 9
Barnet 9
Denver 9
Falkenstein 9
Poplar 9
Baghdad 8
Biên Hòa 8
Chicago 8
Manchester 8
Mumbai 8
New Delhi 8
Porto Alegre 8
Redwood City 8
San Paolo di Civitate 8
Tavernelle 8
Abidjan 7
Auburn Hills 7
Da Nang 7
Istanbul 7
Kingston 7
Philadelphia 7
Quito 7
Amman 6
Caracas 6
Columbus 6
Totale 6.786
Salva come PNG Salva come JPEG
Nome #
Effetti dell’infezione intracellulare da streptococco di gruppo B sierotipo Ia nel macrofago 239
Activity inhibition of cytolytic lymphocytes by omeprazole. 191
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 185
Activation of cytokine genes during primary and anamnestic immune response to inactivated C. albicans 184
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 180
Local and systemic immune response to inactivated C. albicans in mice 172
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 169
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 165
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 161
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 156
Cytokine response to inactivated Candida albicans in mice 153
Group B Streptococcus induces apoptosis in macrophages 151
Experimental model of type IV Streptococcus agalactiae (Group B streptococcus) infection in mice with development of septic arthritis. 151
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 146
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 144
Cytokine response to group B streptococcus infection in mice 144
Macrophage induced gelsolin in response to Group B Streptococcus (GBS) infection 143
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 140
Regolazione redox dell'apoptosi di linfociti B umani. 138
Graft engineering for allogeneic haploidentical stem cell transplantation 138
Cytokine gene expression during in vivo induction of natural killer/lymphokine activated killer cells by inactivated C. albicans cells 138
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 136
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 134
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 133
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 132
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 128
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 123
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 122
Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages 122
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 122
In vitro effects of Meropenem and Imipenem/Cilastatin on some functions of human natural effector cells 119
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 119
Citochine nella risposta immune primaria e secondaria verso la C. albicans inattivata 119
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 118
Silica particle size and shape: in vitro effects on extracellular matrix metabolism and viability of human bronchial epithelial cells. 117
B-chronic lymphocytic leukemia cells exert in vitro cytotoxicity mediated by tumor necrosis factor alpha. 116
Local and systemic immune response to inactivated Candida Albicans in mice. 114
Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. 114
Correlazione fra la induzione nel topo della espressione genica di citochine da parte della C. albicans inattivata ed attivazione di cellule NK/LAK 111
Citochine infiammatorie in risposta alla C. albicans inattivata 111
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 111
Cytokine gene expression during primary and anamnestic immune response to inactivated C. albicans 110
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 107
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 107
L’N-Acetil-L-cisteina inibisce l’apoptosi di linfociti B umani regolando l’attivazione di diverse vie di trasduzione del segnale 106
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C.albicans hyphae in vitro. 106
Is thiol supplementation for potentiang antioxidant defenses a harmless strategy? 105
Espressione di geni per le citochine ed attivazione di cellule NK/LAK da parte della C. albicans inattivata 103
Eventi immunologici precoci nella risposta immune alla C. albicans inattivata 103
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 103
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 102
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 101
Inibizione della attività NK da parte dell’omeprazolo 101
Group B streptococci persist inside macrophages. 97
Attivazione sistemica nel topo di cellule NK/LAK mediante C. albicans inattivata in combinazione con interleuchina-2 ricombinante (rIL-2) 97
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 96
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 95
Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. 95
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 94
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 94
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 93
Macrophage apoptosis induced by Group B Streptococcus 93
In vivo generation of LAK-like cells by inactivated Candida albicans cells. 92
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 92
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 90
In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function. 88
Cytokine response to group B streptococcus infection in mice 88
Antibody-independent protection in mice against type Ia group B streptococcus lethal infection. 87
Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. 84
Inhibition activity of human cytolytic lymphocytes in vitro by omeprazole 84
Impairment of brain mitochondrial functions by ß-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine. 84
C. albicans cell wall components as inducers of LAK-like cells in mice 81
Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine 81
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 79
Artrite cronica sperimentale indotta nel topo mediante infezione sistemica con Streptococco di Gruppo B, Sierotipo IV 78
Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies 77
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 75
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 74
Natural mechanism of resistance to Group B Streptococcus (GBS) type Ia infection in mice. 74
Septic arthritis induced in mice by systemic infection with different serotypes of Group B Streptococci (GBS). 74
Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans. 73
Pathogenic effects of group B streptococcus on macrophages 73
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential 72
Una mannoproteina parietale di C. albicans come modulatore in vivo dell'attività delle cellule NK/LAK 71
Experimental septic arthritis induced by type IV Group B Streptococcus in mice. 70
NOTCH and Graft-Versus-Host Disease 68
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 68
Persistent in vivo activation of NK/LAK cells by inactivated C. albicans and its mannoprotein fraction 67
Modulazione in vivo dell’attività NK/LAK mediante una mannoproteina parietale di C. albicans 67
In vivo modulation of lymphokine-activated killer cell activity by cell wall components of candida albicans. 65
Inibizione in vitro dell’attività citotossica dei linfociti citolitici da parte dell’omeprazolo 64
Immunomodulatory activity of C. albicans and its cell wall components on LAK-like cells induction in mice. 63
Omeprazole inhibition of natural killer cytotoxicity 63
Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation 59
Una mannoproteina di parete di C. albicans come modulatore in vivo dell’attività delle cellule NK/LAK 56
Patogenicità nel topo di diversi ceppi di Streptococcus di Gruppo B Sierotipo IV 54
Componenti di parete della C. albicans come induttori di cellule NK e LAK 54
Produzione in vivo di citochine da parte della C. albicans inattivata ed induzione di cellule NK/LAK 52
Induzione di cellule NK e LAK in vivo: confronto fra la C. albicans ed alcuni "biological response modifiers" 51
Frazioni purificate della parete di C. albicans come modulatori in vivo dell'attività delle cellule LAK 50
Totale 10.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.212
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022849 0 0 20 109 46 9 15 287 16 54 119 174
2022/20231.696 115 230 13 177 150 194 13 84 640 0 50 30
2023/2024692 35 76 46 28 4 20 183 23 65 17 85 110
2024/20251.723 43 156 66 93 218 81 77 115 328 82 315 149
2025/20263.621 252 242 215 490 505 353 588 161 382 295 78 60
2026/2027240 74 84 82 0 0 0 0 0 0 0 0 0
Totale 11.363